TRAILblazing Strategies for Cancer Treatment

In the late 1990s, tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF-family, started receiving much attention for its potential in cancer therapy, due to its capacity to induce apoptosis selectively in tumour cells in vivo. TRAIL binds to its membrane-bound d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kretz, Anna-Laura, Trauzold, Anna, Hillenbrand, Andreas, Knippschild, Uwe, Henne-Bruns, Doris, von Karstedt, Silvia, Lemke, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521007/
https://www.ncbi.nlm.nih.gov/pubmed/30935038
http://dx.doi.org/10.3390/cancers11040456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521007/
https://www.ncbi.nlm.nih.gov/pubmed/30935038
http://dx.doi.org/10.3390/cancers11040456

Ejemplares similares